Comparison of ICare rebound tonometer with noncontact tonometer in healthy children

Mitsuyo Kageyama1, Kazuyuki Hirooka, Tetsuya Baba

  • 1Department of Ophthalmology, Kagawa University, Kagawa, Japan.

Journal of Glaucoma
|February 25, 2010
PubMed

Insights

The ICare rebound tonometer is more effective and better tolerated for measuring intraocular pressure (IOP) in children than the noncontact tonometer (NCT), particularly for those under six years old.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Medical Device Technology

Background:

  • Accurate intraocular pressure (IOP) measurement is crucial for diagnosing and monitoring pediatric eye conditions.
  • Noncontact tonometers (NCT) and rebound tonometers (ICare) are commonly used for IOP assessment.
  • Limited data exists comparing the efficacy and tolerance of these devices in healthy children.

Purpose of the Study:

  • To compare the effectiveness and patient tolerance of the ICare rebound tonometer versus the noncontact tonometer (NCT) for measuring intraocular pressure (IOP) in healthy children.
  • To determine which tonometer provides a higher success rate for IOP measurement in pediatric patients.
  • To assess the device preference in different age groups within the pediatric population.

Main Methods:

  • A prospective observational study involving 180 healthy children aged 6 months to 15 years.
  • Intraocular pressure was measured using both ICare and NCT devices without anesthesia.
  • The McNemar test was employed to compare the success rates and tolerance between the two devices.

Main Results:

  • The ICare tonometer achieved a successful IOP measurement in 88.9% of children, compared to 72.2% with the NCT.
  • ICare demonstrated significantly better tolerance, especially in children younger than 6 years (P<0.001).
  • Mean IOP differences (95% limits of agreement) were 0.90±6.40 mm Hg (right eye) and 1.18±6.19 mm Hg (left eye) between devices.

Conclusions:

  • The ICare rebound tonometer is more effective and better tolerated for IOP measurement in the pediatric population than the NCT.
  • These findings are particularly relevant for children under the age of 6, where ICare shows a clear advantage.
  • The study supports the use of ICare for routine IOP assessment in children, enhancing diagnostic capabilities and patient comfort.
Abstract